• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌蛋白18是一种微管动力学的磷酸化反应调节因子。

Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics.

作者信息

Marklund U, Larsson N, Gradin H M, Brattsand G, Gullberg M

机构信息

Department of Cell and Molecular Biology, University of Umeå, Sweden.

出版信息

EMBO J. 1996 Oct 1;15(19):5290-8.

PMID:8895574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC452273/
Abstract

Oncoprotein 18 (Op18, also termed p19, p18, prosolin or stathmin) is a cytosolic protein of previously unknown function. Phosphorylation of Op18 is cell cycle regulated by cyclin-dependent kinases (CDKs), and expression of a 'CDK target site-deficient mutant' results in a phenotype indicative of a role for Op18 during mitosis. This phenotype is compatible with the idea that Op18 is a phosphorylation-responsive regulator of microtubule (MT) dynamics. Therefore, in this study, we analyzed MTs in cells induced to express either wild-type or mutated Op18. The results showed that wild-type Op18 and a CDK target site mutant both efficiently elicited rapid depolymerization of MTs. This result contrasts with clear-cut differences in their cell cycle phenotypes. Morphological analysis of MTs explained this apparent discrepancy: while interphase MTs were depolymerized in cells expressing either Op18 derivative, apparently normal mitotic spindles were formed only in cells overexpressing wild-type Op18. This result correlates with our finding that only mutated Op18 causes a block during mitosis. Hence, we conclude that Op18 decreases MT stability and that this activity of Op18 is subject to cell cycle regulation by CDKs.

摘要

癌蛋白18(Op18,也称为p19、p18、prosolin或stathmin)是一种功能未知的胞质蛋白。Op18的磷酸化受细胞周期蛋白依赖性激酶(CDK)调控,“缺乏CDK靶位点突变体”的表达导致一种表型,表明Op18在有丝分裂过程中发挥作用。这种表型与Op18是微管(MT)动力学的磷酸化反应调节因子这一观点相符。因此,在本研究中,我们分析了诱导表达野生型或突变型Op18的细胞中的微管。结果表明,野生型Op18和一个CDK靶位点突变体均能有效引发微管的快速解聚。这一结果与它们在细胞周期表型上的明显差异形成对比。对微管的形态学分析解释了这一明显的差异:虽然在表达任何一种Op18衍生物的细胞中,间期微管都会解聚,但只有在过表达野生型Op18的细胞中才能形成明显正常的有丝分裂纺锤体。这一结果与我们的发现相关,即只有突变型Op18会在有丝分裂过程中导致阻滞。因此,我们得出结论,Op18会降低微管稳定性,且Op18的这一活性受CDK的细胞周期调控。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee1/452273/31ffb0ebae3a/emboj00019-0176-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee1/452273/06ab52ce666d/emboj00019-0173-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee1/452273/3e7fcce08b80/emboj00019-0174-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee1/452273/91be701a143d/emboj00019-0175-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee1/452273/31ffb0ebae3a/emboj00019-0176-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee1/452273/06ab52ce666d/emboj00019-0173-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee1/452273/3e7fcce08b80/emboj00019-0174-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee1/452273/91be701a143d/emboj00019-0175-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee1/452273/31ffb0ebae3a/emboj00019-0176-a.jpg

相似文献

1
Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics.癌蛋白18是一种微管动力学的磷酸化反应调节因子。
EMBO J. 1996 Oct 1;15(19):5290-8.
2
Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis.原癌蛋白18对微管动力学的调控:剖析有丝分裂期间多位点磷酸化的调节作用。
Mol Cell Biol. 1997 Sep;17(9):5530-9. doi: 10.1128/MCB.17.9.5530.
3
The phenotype of a "Cdc2 kinase target site-deficient" mutant of oncoprotein 18 reveals a role of this protein in cell cycle control.癌蛋白18的“Cdc2激酶靶点位点缺陷型”突变体的表型揭示了该蛋白在细胞周期调控中的作用。
J Biol Chem. 1994 Dec 2;269(48):30626-35.
4
The catastrophe-promoting activity of ectopic Op18/stathmin is required for disruption of mitotic spindles but not interphase microtubules.异位Op18/微管相关蛋白的促灾难活性是有丝分裂纺锤体破坏所必需的,但不是间期微管破坏所必需的。
Mol Biol Cell. 2001 Jan;12(1):73-83. doi: 10.1091/mbc.12.1.73.
5
Autonomous and phosphorylation-responsive microtubule-regulating activities of the N-terminus of Op18/stathmin.Op18/原癌蛋白18 N端的自主及磷酸化响应性微管调节活性
J Cell Sci. 2003 Jan 1;116(Pt 1):197-205. doi: 10.1242/jcs.00205.
6
Stathmin/Op18 phosphorylation is regulated by microtubule assembly.Stathmin/Op18磷酸化受微管组装调控。
Mol Biol Cell. 2001 Feb;12(2):437-48. doi: 10.1091/mbc.12.2.437.
7
Op18/stathmin mediates multiple region-specific tubulin and microtubule-regulating activities.Op18/微管相关蛋白介导多种区域特异性微管蛋白和微管调节活性。
J Cell Biol. 1999 Sep 20;146(6):1289-302. doi: 10.1083/jcb.146.6.1289.
8
Regulation of microtubule dynamics by Ca2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18.通过癌蛋白18的Ca2+/钙调蛋白依赖性激酶IV/Gr依赖性磷酸化对微管动力学进行调控
Mol Cell Biol. 1997 Jun;17(6):3459-67. doi: 10.1128/MCB.17.6.3459.
9
Oncoprotein 18 levels and phosphorylation mediate megakaryocyte polyploidization in human erythroleukemia cells.癌蛋白18水平和磷酸化介导人红白血病细胞中的巨核细胞多倍体化。
Proteomics. 2001 Nov;1(11):1415-23. doi: 10.1002/1615-9861(200111)1:11<1415::AID-PROT1415>3.0.CO;2-F.
10
Regulation of microtubule dynamics by extracellular signals: cAMP-dependent protein kinase switches off the activity of oncoprotein 18 in intact cells.细胞外信号对微管动力学的调节:环磷酸腺苷依赖性蛋白激酶在完整细胞中关闭癌蛋白18的活性。
J Cell Biol. 1998 Jan 12;140(1):131-41. doi: 10.1083/jcb.140.1.131.

引用本文的文献

1
Tubulin Regulates the Stability and Localization of STMN2 by Binding Preferentially to Its Soluble Form.微管蛋白通过优先结合其可溶性形式来调节STMN2的稳定性和定位。
bioRxiv. 2025 Feb 28:2025.02.27.640326. doi: 10.1101/2025.02.27.640326.
2
Survivin as a Therapeutic Target for the Treatment of Human Cancer.生存素作为治疗人类癌症的治疗靶点。
Cancers (Basel). 2024 Apr 27;16(9):1705. doi: 10.3390/cancers16091705.
3
STMND1 is a phylogenetically ancient stathmin which localizes to motile cilia and exhibits nuclear translocation that is inhibited when soluble tubulin concentration increases.

本文引用的文献

1
Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules.鉴定一种与微管蛋白二聚体相互作用并提高微管解聚速率的蛋白质。
Cell. 1996 Feb 23;84(4):623-31. doi: 10.1016/s0092-8674(00)81037-5.
2
Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells.正常细胞和肿瘤细胞中一种激活调节磷蛋白(癌蛋白18)的表达及调控的定量分析
Leukemia. 1993 Apr;7(4):569-79.
3
Expression of oncoprotein 18 in human leukemias and lymphomas.
STMND1 是一种进化上古老的 stathmin,定位于运动纤毛,并表现出核易位,当可溶性微管蛋白浓度增加时,核易位被抑制。
Mol Biol Cell. 2024 Jun 1;35(6):ar82. doi: 10.1091/mbc.E23-12-0514. Epub 2024 Apr 17.
4
Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation.Stathmin-2 的缺失导致神经丝依赖性轴突崩溃,从而导致运动和感觉神经支配丧失。
Nat Neurosci. 2024 Jan;27(1):34-47. doi: 10.1038/s41593-023-01496-0. Epub 2023 Nov 23.
5
The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms.外泌体非编码RNA在乳腺癌耐药中的研究概况,重点关注潜在分子机制。
Front Pharmacol. 2023 Apr 19;14:1152672. doi: 10.3389/fphar.2023.1152672. eCollection 2023.
6
Landscape of NcRNAs involved in drug resistance of breast cancer.参与乳腺癌耐药的非编码 RNA 景观。
Clin Transl Oncol. 2023 Jul;25(7):1869-1892. doi: 10.1007/s12094-023-03189-3. Epub 2023 Apr 17.
7
E2F1 promotes cell cycle progression by stabilizing spindle fiber in colorectal cancer cells.E2F1 通过稳定结直肠癌细胞中的纺锤体纤维促进细胞周期进程。
Cell Mol Biol Lett. 2022 Oct 11;27(1):90. doi: 10.1186/s11658-022-00392-y.
8
Simvastatin Downregulates Cofilin and Stathmin to Inhibit Skeletal Muscle Cells Migration.辛伐他汀通过下调原肌球蛋白和微管相关蛋白抑制骨骼肌细胞迁移。
Int J Mol Sci. 2022 Mar 5;23(5):2848. doi: 10.3390/ijms23052848.
9
TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer.作为乳腺癌新治疗靶点的瞬时受体电位通道相互作用组
Front Oncol. 2021 Jun 10;11:621614. doi: 10.3389/fonc.2021.621614. eCollection 2021.
10
The Rac-GAP alpha2-Chimaerin Signals via CRMP2 and Stathmins in the Development of the Ocular Motor System.α2- Rac GAP 衔接蛋白通过 CRMP2 和 Stathmin 信号通路在眼运动系统发育中发挥作用。
J Neurosci. 2021 Aug 4;41(31):6652-6672. doi: 10.1523/JNEUROSCI.0983-19.2021. Epub 2021 Jun 24.
癌蛋白18在人类白血病和淋巴瘤中的表达。
Leukemia. 1993 Oct;7(10):1538-46.
4
Multiple phosphorylation of stathmin. Identification of four sites phosphorylated in intact cells and in vitro by cyclic AMP-dependent protein kinase and p34cdc2.信号素的多重磷酸化。完整细胞中以及体外由环磷酸腺苷依赖性蛋白激酶和p34cdc2磷酸化的四个位点的鉴定。
J Biol Chem. 1993 Sep 25;268(27):20076-84.
5
Serine 25 of oncoprotein 18 is a major cytosolic target for the mitogen-activated protein kinase.癌蛋白18的丝氨酸25是丝裂原活化蛋白激酶的主要胞质靶点。
J Biol Chem. 1993 Jul 15;268(20):15039-47.
6
Molecular diversity of the SCG10/stathmin gene family in the mouse.小鼠中SCG10/微管相关蛋白Stathmin基因家族的分子多样性
Genomics. 1993 Nov;18(2):360-73. doi: 10.1006/geno.1993.1477.
7
Multiple signal transduction pathways induce phosphorylation of serines 16, 25, and 38 of oncoprotein 18 in T lymphocytes.多种信号转导途径可诱导T淋巴细胞中癌蛋白18的丝氨酸16、25和38位点发生磷酸化。
J Biol Chem. 1993 Dec 5;268(34):25671-80.
8
Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase.白血病细胞中磷蛋白p18的调控。p34cdc2激酶对细胞周期的调控磷酸化作用。
J Biol Chem. 1994 Apr 8;269(14):10312-8.
9
Cell-cycle-regulated phosphorylation of oncoprotein 18 on Ser16, Ser25 and Ser38.癌蛋白18在丝氨酸16、丝氨酸25和丝氨酸38位点的细胞周期调控磷酸化作用
Eur J Biochem. 1994 Mar 1;220(2):359-68. doi: 10.1111/j.1432-1033.1994.tb18632.x.
10
The phenotype of a "Cdc2 kinase target site-deficient" mutant of oncoprotein 18 reveals a role of this protein in cell cycle control.癌蛋白18的“Cdc2激酶靶点位点缺陷型”突变体的表型揭示了该蛋白在细胞周期调控中的作用。
J Biol Chem. 1994 Dec 2;269(48):30626-35.